ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 596,49
0,61%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sciele Pharma (MM) (SCRX)

  7. Sciele Pharma (MM) (SCRX) Actualités

SCRX

Sciele Pharma (MM) (SCRX)

Sciele Pharma (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SCRX
DateHeureSourceTitreSymboleSociété
25/08/202119h00Business WiretheScore Bet Becomes Official Gaming Partner of Golf Canada and its Marquee Golf Championships, the RBC Canadian Open and CP Women’s OpenNASDAQ:SCRXSciele Pharma (MM)
19/08/202116h00Business WiretheScore Selects Toronto’s Waterfront Innovation Centre as Site for New, Expansive HeadquartersNASDAQ:SCRXSciele Pharma (MM)
05/08/202113h01Business WirePenn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology CompanyNASDAQ:SCRXSciele Pharma (MM)
13/07/202123h01Business WiretheScore Reports F2021 Q3 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
06/07/202113h30Business WiretheScore to Report Q3 F2021 Financial Results on Tuesday, July 13, 2021NASDAQ:SCRXSciele Pharma (MM)
22/06/202122h16Business WiretheScore Applauds Passage by the Senate of Historic Legislation to Legalize Single Event Sports Betting in CanadaNASDAQ:SCRXSciele Pharma (MM)
23/04/202101h41Business WiretheScore Issues Statement Following the Passing of Bill C-218 by the House of CommonsNASDAQ:SCRXSciele Pharma (MM)
13/04/202123h02Business WiretheScore Reports Record F2021 Q2 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
06/04/202113h45Business WiretheScore To Report Q2 F2021 Financial Results on Tuesday, April 13, 2021NASDAQ:SCRXSciele Pharma (MM)
30/03/202119h02Business WirePGA TOUR Announces theScore Bet as an Official Betting OperatorNASDAQ:SCRXSciele Pharma (MM)
29/03/202114h30Business WiretheScore Secures Market Access for Mobile Sports Betting in Illinois Through Agreement with Caesars EntertainmentNASDAQ:SCRXSciele Pharma (MM)
01/03/202117h04Business WiretheScore Announces Closing of US$186.3 Million Initial Public Offering in the United StatesNASDAQ:SCRXSciele Pharma (MM)
09/10/200823h01Business WireShionogi Completes Acquisition of ScieleNASDAQ:SCRXSciele Pharma (MM)
09/10/200817h10Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
09/10/200814h02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
09/10/200813h30Business WireShionogi and Sciele Announce Completion of Subsequent Offering PeriodNASDAQ:SCRXSciele Pharma (MM)
06/10/200815h54Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
06/10/200812h30Business WireShionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent OfferingNASDAQ:SCRXSciele Pharma (MM)
06/10/200812h05Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
26/09/200801h38PR Newswire (US)Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. IndicesNASDAQ:SCRXSciele Pharma (MM)
19/09/200812h00Business WireShionogi and Sciele Announce Receipt of United States Antitrust ClearanceNASDAQ:SCRXSciele Pharma (MM)
16/09/200815h46Business WireSciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe DroolingNASDAQ:SCRXSciele Pharma (MM)
08/09/200817h19Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
08/09/200817h03Edgar (US Regulatory)Sciele Pharma, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:SCRXSciele Pharma (MM)
03/09/200822h49Edgar (US Regulatory)Sciele Pharma, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:SCRXSciele Pharma (MM)
03/09/200822h47Edgar (US Regulatory)Sciele Pharma, Inc. - Current report filing (8-K)NASDAQ:SCRXSciele Pharma (MM)
02/09/200820h14Edgar (US Regulatory)Sciele Pharma, Inc. - Written communication relating to an issuer or third party (SC TO-C)NASDAQ:SCRXSciele Pharma (MM)
02/09/200817h44MarketwiredBellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISILNASDAQ:SCRXSciele Pharma (MM)
01/09/200811h01Business WireShionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.NASDAQ:SCRXSciele Pharma (MM)
27/08/200816h10Edgar (US Regulatory)Sciele Pharma, Inc. - Initial Statement of Beneficial Ownership (3)NASDAQ:SCRXSciele Pharma (MM)
 Showing the most relevant articles for your search:NASDAQ:SCRX

Dernières Valeurs Consultées

NYSE
NKE
Nike
NYSE
MRK
Merck
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
EU
ORA
Orange
EU
PX4
SBF 120
EU
ML
Michelin
EU
ACA
Credit Agricole
EU
HO
Thales
COIN
ETHUSD
Ethereum
COIN
BTCUSD
Bitcoin
EU
AI
Air Liquide
EU
DG
Vinci
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés